Belgian clinical-stage biotechnology company that discovers and develops small molecule medicines, also making selective strategic investments in complementary biotech ventures.

Mechelen, Belgium · 3+ investments · 3 portfolio companies

Early Stage
Biotech
Headquarters
Mechelen, Belgium
Founded
1999
Website
glpg.com
Portfolio Companies
3
Total Investments
3
Last Investment
Apr 2026
Geographic Focus
Europe, United States

Investment Thesis

Makes selective strategic biotech investments extending its own pipeline science, as shown by its stake in Coultreon Biopharma's $125M Series A for immunology therapies derived from former Galapagos assets.

Galapagos is a Venture Capital firm based in Mechelen, Belgium. It has made 3 investments, including Altis, Coultreon Biopharma and Frontier Medicines. Focus areas include Biotech.

Portfolio3

Co-investors13

Sign up to view co-investors

13 co-investors across 13 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×11 · Private Equity ×1 · Corporate VC ×1 · 6 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Galapagos on Indexed.vc
<a href="https://indexed.vc/investors/galapagos"><img src="https://indexed.vc/api/badge/investor/galapagos" alt="Galapagos on Indexed.vc" width="260" height="76" /></a>